
Bong-sook Baek
Examiner (ID: 15901, Phone: (571)270-5863 , Office: P/1621 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1629, 1611, 1614, 1621, 4161 |
| Total Applications | 1160 |
| Issued Applications | 484 |
| Pending Applications | 95 |
| Abandoned Applications | 604 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20307845
[patent_doc_number] => 20250325474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-23
[patent_title] => AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 19/254167
[patent_app_country] => US
[patent_app_date] => 2025-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19254167
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/254167 | AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION | Jun 29, 2025 | Pending |
Array
(
[id] => 20048155
[patent_doc_number] => 20250186377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => METHODS OF ADMINISTERING GAMMA-HYDROXYBUTYRATE COMPOSITIONS WITH DIVALPROEX SODIUM
[patent_app_type] => utility
[patent_app_number] => 19/056265
[patent_app_country] => US
[patent_app_date] => 2025-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19056265
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/056265 | METHODS OF ADMINISTERING GAMMA-HYDROXYBUTYRATE COMPOSITIONS WITH DIVALPROEX SODIUM | Feb 17, 2025 | Abandoned |
Array
(
[id] => 19875789
[patent_doc_number] => 20250108046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => APPARATUS, METHODS, AND SYSTEMS FOR PROVIDING PHARMACEUTICAL COMPOSITIONS IN THE FORM OF DROPLETS FOR AEROSOL ADMINISTRATION AND INHALATION DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/977526
[patent_app_country] => US
[patent_app_date] => 2024-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18977526
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/977526 | APPARATUS, METHODS, AND SYSTEMS FOR PROVIDING PHARMACEUTICAL COMPOSITIONS IN THE FORM OF DROPLETS FOR AEROSOL ADMINISTRATION AND INHALATION DELIVERY | Dec 10, 2024 | Pending |
Array
(
[id] => 19875789
[patent_doc_number] => 20250108046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => APPARATUS, METHODS, AND SYSTEMS FOR PROVIDING PHARMACEUTICAL COMPOSITIONS IN THE FORM OF DROPLETS FOR AEROSOL ADMINISTRATION AND INHALATION DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/977526
[patent_app_country] => US
[patent_app_date] => 2024-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18977526
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/977526 | APPARATUS, METHODS, AND SYSTEMS FOR PROVIDING PHARMACEUTICAL COMPOSITIONS IN THE FORM OF DROPLETS FOR AEROSOL ADMINISTRATION AND INHALATION DELIVERY | Dec 10, 2024 | Pending |
Array
(
[id] => 20356257
[patent_doc_number] => 12472236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Compositions and methods for treating diabetes
[patent_app_type] => utility
[patent_app_number] => 18/967455
[patent_app_country] => US
[patent_app_date] => 2024-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 21784
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18967455
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/967455 | Compositions and methods for treating diabetes | Dec 2, 2024 | Issued |
Array
(
[id] => 19798801
[patent_doc_number] => 20250064726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 18/944456
[patent_app_country] => US
[patent_app_date] => 2024-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18944456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/944456 | Aqueous suspension suitable for oral administration | Nov 11, 2024 | Issued |
Array
(
[id] => 19798801
[patent_doc_number] => 20250064726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 18/944456
[patent_app_country] => US
[patent_app_date] => 2024-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18944456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/944456 | Aqueous suspension suitable for oral administration | Nov 11, 2024 | Issued |
Array
(
[id] => 19875799
[patent_doc_number] => 20250108056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE
[patent_app_type] => utility
[patent_app_number] => 18/749901
[patent_app_country] => US
[patent_app_date] => 2024-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18749901
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/749901 | SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE | Jun 20, 2024 | Pending |
Array
(
[id] => 19707756
[patent_doc_number] => 20250017898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => COMPOSITIONS AND METHODS FOR ACTIVATING NRF2-DEPENDENT GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/739544
[patent_app_country] => US
[patent_app_date] => 2024-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18739544
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/739544 | COMPOSITIONS AND METHODS FOR ACTIVATING NRF2-DEPENDENT GENE EXPRESSION | Jun 10, 2024 | Pending |
Array
(
[id] => 19447203
[patent_doc_number] => 20240307333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => ANTI-VIRAL THERAPEUTIC AGENTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/737662
[patent_app_country] => US
[patent_app_date] => 2024-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18737662
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/737662 | ANTI-VIRAL THERAPEUTIC AGENTS AND USES THEREOF | Jun 6, 2024 | Pending |
Array
(
[id] => 19613046
[patent_doc_number] => 20240398726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => SOLUBLE CURCUMIN AND ITS DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/732567
[patent_app_country] => US
[patent_app_date] => 2024-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18732567
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/732567 | SOLUBLE CURCUMIN AND ITS DERIVATIVES | Jun 2, 2024 | Pending |
Array
(
[id] => 19447247
[patent_doc_number] => 20240307377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => METHOD OF TREATMENT OF DEPRESSED PATIENTS WITH POOR COGNITION AND SELECTION OF OTHER PATIENTS BENEFITING FROM A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT
[patent_app_type] => utility
[patent_app_number] => 18/670599
[patent_app_country] => US
[patent_app_date] => 2024-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18670599
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/670599 | METHOD OF TREATMENT OF DEPRESSED PATIENTS WITH POOR COGNITION AND SELECTION OF OTHER PATIENTS BENEFITING FROM A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT | May 20, 2024 | Abandoned |
Array
(
[id] => 19360762
[patent_doc_number] => 20240262796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/620876
[patent_app_country] => US
[patent_app_date] => 2024-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 302
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18620876
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/620876 | SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE | Mar 27, 2024 | Pending |
Array
(
[id] => 19360762
[patent_doc_number] => 20240262796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/620876
[patent_app_country] => US
[patent_app_date] => 2024-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 302
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18620876
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/620876 | SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE | Mar 27, 2024 | Pending |
Array
(
[id] => 19477334
[patent_doc_number] => 20240325376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => COMPOSITIONS AND METHODS FOR ADMINISTERING PALTUSOTINE TO PATIENTS WITH HEPATIC IMPAIRMENT
[patent_app_type] => utility
[patent_app_number] => 18/615512
[patent_app_country] => US
[patent_app_date] => 2024-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18615512
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/615512 | Compositions and methods for administering paltusotine to patients with hepatic impairment | Mar 24, 2024 | Issued |
Array
(
[id] => 19297491
[patent_doc_number] => 20240226056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => Sleep or Post-Sleep Performance
[patent_app_type] => utility
[patent_app_number] => 18/613524
[patent_app_country] => US
[patent_app_date] => 2024-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613524
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/613524 | Sleep or Post-Sleep Performance | Mar 21, 2024 | Pending |
Array
(
[id] => 19578724
[patent_doc_number] => 12144806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Quinolines that modulate SERCA and their use for treating disease
[patent_app_type] => utility
[patent_app_number] => 18/588191
[patent_app_country] => US
[patent_app_date] => 2024-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 25480
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18588191
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/588191 | Quinolines that modulate SERCA and their use for treating disease | Feb 26, 2024 | Issued |
Array
(
[id] => 20039229
[patent_doc_number] => 20250177451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => EXTRACELLULAR VESICLES FOR THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/581843
[patent_app_country] => US
[patent_app_date] => 2024-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581843
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/581843 | EXTRACELLULAR VESICLES FOR THERAPY | Feb 19, 2024 | Pending |
Array
(
[id] => 20039229
[patent_doc_number] => 20250177451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => EXTRACELLULAR VESICLES FOR THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/581843
[patent_app_country] => US
[patent_app_date] => 2024-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581843
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/581843 | EXTRACELLULAR VESICLES FOR THERAPY | Feb 19, 2024 | Pending |
Array
(
[id] => 19201353
[patent_doc_number] => 20240173252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 18/426972
[patent_app_country] => US
[patent_app_date] => 2024-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18426972
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/426972 | Aqueous suspension suitable for oral administration | Jan 29, 2024 | Issued |